Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer.
Gachechiladze M, Uberall I, Kolek V, Klein J, Krejci V, Stastna J, Radova L, Fridman E, Skarda J. Gachechiladze M, et al. Among authors: kolek v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Sep;157(3):227-32. doi: 10.5507/bp.2012.099. Epub 2012 Nov 1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013. PMID: 23128816 Free article.
Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine.
Gachechiladze M, Tichý T, Kolek V, Grygárková I, Klein J, Mgebrishvili G, Kharaishvili G, Janíková M, Smičková P, Cierna L, Pitson S, Maddelein ML, Cuvillier O, Škarda J. Gachechiladze M, et al. Among authors: kolek v. Oncol Lett. 2019 Aug;18(2):1259-1266. doi: 10.3892/ol.2019.10447. Epub 2019 Jun 7. Oncol Lett. 2019. PMID: 31423186 Free PMC article.
Analysis of the prognostic impact of nestin expression in non-small cell lung cancer.
Skarda J, Kolar Z, Janikova M, Radova L, Kolek V, Fridman E, Kopolovic J. Skarda J, et al. Among authors: kolek v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Jun;156(2):135-42. doi: 10.5507/bp.2012.036. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012. PMID: 22837134 Free article.
Long term follow-up of neoadjuvant-adjuvant combination treatment of IIIA stage non-small-cell-lung cancer: results of neoadjuvant carboplatin/vinorelbine and carboplatin/paclitaxel regimens combined with selective adjuvant chemotherapy according to in-vitro chemoresistance test.
Kolek V, Grygarkova I, Hajduch M, Klein J, Cwiertka K, Neoral C, Langova K, Mihal V. Kolek V, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Dec;152(2):259-66. doi: 10.5507/bp.2008.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008. PMID: 19219217 Free article. Clinical Trial.
181 results